Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.
for
Wilson's Disease
Location: Denver CO
Sponsor: Orphalan
Sex: All
Age: 8+
Code: NCT07465718
Phase3, Recruiting
New
Early Intervention With Inhaled Treprostinil Among Patients With Exercise-Induced Pulmonary Hypertension (EPIH)
for
Pulmonary Hypertension
Location: Paramus NJ
Sponsor: Valley Health System
Sex: All
Age: 18+
Code: NCT07837830
Early_phase1, Recruiting
Active & ResponsiveNew
Textured Insoles to Restore Sensorimotor Function in Patients With Plantar Fasciopathy
for
Plantar Fasciopathy
Location: Lexington KY
Sponsor: Jennifer Xu
Sex: All
Age: 18 - 55
Code: NCT07765082
Recruiting
New
Virtual Reality Aniseikonia and Metamorphopsia Testing
for
Metamorphopsia, Aniseikonia
Location: New York NY
Sponsor: NYU Langone Health
Sex: All
Age: 18+
Code: NCT07838181
Recruiting
Active & ResponsiveNew
Stanford Healthy Goals Study
for
Obesity, Childhood
Location: Stanford CA
Sponsor: Stanford University
Sex: All
Age: 10 - 15
Code: NCT07839832
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & ResponsiveNew
MenoZen VR for Menopause Symptom Management
for
Menopause
Location: Jacksonville FL
Sponsor: Mayo Clinic
Sex: Female
Age: 45 - 60
Code: NCT07633743
Recruiting
New
A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)
Sponsor: Weill Medical College of Cornell University
Sex: All
Age: 18+
Code: NCT07661966
Recruiting
New
Mobile Sun Health Intervention EnabLing Daily Protection
for
Skin Cancer
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: All
Age: 18 - 29
Code: NCT07830394
Recruiting
New
A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)